We are live on
!
Find out more
DCI
Data Collective IV Portfolio holdings
AUM
$55.9M
1-Year Est. Return
49.14%
This Fund
S&P 500
This Quarter
Est. Return
-15.85%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$741M
AUM Growth
–
Cap. Flow
+$797M
Cap. Flow
% of AUM
107.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMBK
Embark Technology, Inc. Common Stock
EMBK
|
+$582M |
| 2 |
Recursion Pharmaceuticals
RXRX
|
+$112M |
| 3 |
Evolv Technologies
EVLV
|
+$59.5M |
| 4 |
Rocket Lab Corp
RKLB
|
+$40.2M |
| 5 |
DFTX
Definium Therapeutics
DFTX
|
+$3.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 74.67% |
| 2 | Healthcare | 14.09% |
| 3 | Industrials | 11.24% |
Similar funds
BWA
JRCM
OFA
LCM
EI
CTFG
AA
CAM
Data Collective IV's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Data Collective IV, which disclosed 5 positions worth $741M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Embark Technology, Inc. Common Stock: 3,186,008 shares worth $553M.
By sector, the portfolio is most concentrated in Technology at 75% of assets, followed by Healthcare and Industrials.
- Data Collective IV's largest Q4 2021 buy was Embark Technology, Inc. Common Stock: 3,186,008 shares worth $553M.
- Data Collective IV's ten largest holdings make up 100% of its $741M portfolio in Q4 2021.
- Data Collective IV disclosed 5 positions in Q4 2021, its first 13F filing on record.
Based on Data Collective IV's 13F filing for Q4 2021, filed 14 Feb 2022.